GEORGETTE MODULE 1 COMPREHENSIVE
STUDY SHEET 2026 PRACTICE QUESTIONS
WITH COMPLETE ANSWERS FULL
SOLUTION PACK GRADED A+
⩥ DAST 10.
Answer: designed to assess alcohol dependence - may not capture the
full spectrum of alcohol use
** less comprehensive than the AUDIT
⩥ Michigan Alcohol Screening Test (MAST).
Answer: older screening tool for alcohol use
*AUDIT -more up to date/comprehensive in assessing alcohol use and
related problems
⩥ patient is having significant opioid withdrawal symptoms. which
medication do you give?.
Answer: buprenorphine/Suboxone (buprenorphine and naloxone)
, buprenorphine- partial opioid agonist ( safer than methadone) - has a
lower risk of overdose and respiratory depression, reduced risk of
diversion and misuse
Suboxone ( is a combination of buprenorphine with naloxone) - provides
additional safety by deterring misuse
⩥ Methadone.
Answer: can be effective for opioid withdrawal management- but it is
associated with higher risk of overdose and respiratory depression (
especially when not administered and monitored appropriately)
⩥ Naloxone.
Answer: opioid receptor antagonist- used to reverse opioid overdoes -
NOT suitable for managing withdrawal symptoms
⩥ naltrexone.
Answer: opioid receptor antagonist- not appropriate for managing opioid
withdrawal symptoms
helps to prevent relapse in patients who have already undergone detox
⩥ patient with alcohol withdrawal who has liver disease.
STUDY SHEET 2026 PRACTICE QUESTIONS
WITH COMPLETE ANSWERS FULL
SOLUTION PACK GRADED A+
⩥ DAST 10.
Answer: designed to assess alcohol dependence - may not capture the
full spectrum of alcohol use
** less comprehensive than the AUDIT
⩥ Michigan Alcohol Screening Test (MAST).
Answer: older screening tool for alcohol use
*AUDIT -more up to date/comprehensive in assessing alcohol use and
related problems
⩥ patient is having significant opioid withdrawal symptoms. which
medication do you give?.
Answer: buprenorphine/Suboxone (buprenorphine and naloxone)
, buprenorphine- partial opioid agonist ( safer than methadone) - has a
lower risk of overdose and respiratory depression, reduced risk of
diversion and misuse
Suboxone ( is a combination of buprenorphine with naloxone) - provides
additional safety by deterring misuse
⩥ Methadone.
Answer: can be effective for opioid withdrawal management- but it is
associated with higher risk of overdose and respiratory depression (
especially when not administered and monitored appropriately)
⩥ Naloxone.
Answer: opioid receptor antagonist- used to reverse opioid overdoes -
NOT suitable for managing withdrawal symptoms
⩥ naltrexone.
Answer: opioid receptor antagonist- not appropriate for managing opioid
withdrawal symptoms
helps to prevent relapse in patients who have already undergone detox
⩥ patient with alcohol withdrawal who has liver disease.
